Replies to post #155425 on Anavex Life Sciences Corp (AVXL)

[bas2020]

What would prevent a hostile takeover?

[jimmy667]

If A2-73 proves out they could likely license it for MS indication alone for $3 Billion plus royalties. That alone would gain each shareholder $50 a share at current OSCount. Research the Allergan/Heptares deal and other recent drug license deals. That boatload of upfront cash will fully fund the Company as an Independent for all other indications.